Lente insulin. 1954

GREENHOUSE B

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D061405 Insulin, Lente An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage. Insulin Novo Monotard,Insulin, Lente, Monocomponent,Insulin, Monotard,Lente Insulin,Monotard Insulin,Monotard, Insulin Novo,Novo Monotard, Insulin

Related Publications

GREENHOUSE B
November 1953, British medical journal,
GREENHOUSE B
October 1955, Northwest medicine,
GREENHOUSE B
November 1956, Lancet (London, England),
GREENHOUSE B
February 1956, Journal of the American Geriatrics Society,
GREENHOUSE B
May 1958, Deutsche medizinische Wochenschrift (1946),
GREENHOUSE B
January 1956, Diabetes,
GREENHOUSE B
April 1958, Deutsche medizinische Wochenschrift (1946),
GREENHOUSE B
July 1957, Journal - Michigan State Medical Society,
GREENHOUSE B
February 1955, Deutsche medizinische Wochenschrift (1946),
GREENHOUSE B
April 1985, Diabetologia,
Copied contents to your clipboard!